Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Mit der Ausbreitung der neuesten Affenpocken-Variante außerhalb Afrikas verzeichnen kleine Diagnostikunternehmen beeindruckende Kursgewinne. Investoren setzen auf steigende Nachfrage nach Tests und Impfstoffen.
